English
+38 068 889 89 89
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Contact us

News and articles on cancer

Stem cell treatment protects bone marrow from damaging chemotherapy effects in cancer patients

12 May 2012

Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.

All news

Cancer

Fetal stem cell treatment is not an alternative to standard protocols of treating cancer. Stem cell therapy is possible only after surgery and/or traditional chemo- and/or radiotherapy, in case they are indicated to the patient.

We accept for treatment cancer patients with stabilized condition proved by results of instrumental and laboratory findings there should be no primary tumor growth or new metastasis formation.

As conventional cancer treatment has many side effects, stem cell treatment is aimed mainly at:

  • Partial restoration of anti-tumor immunity and haemopoesis;
  • Improvement in patient’s quality of life – reduced weakness, better overall condition, both physical and psycho-emotional.

During the first month after stem cell treatment, our patients may observe the following effects:

  • improved overall condition and appetite;
  • diminished weakness and sweating;
  • increased capacity to work and self-care ability;
  • better emotional status, cognitive abilities and memory.

Within one to two months after fetal stem cells transplantation, other positive effects develop (some of them translate into improved laboratory findings), in particular:

  • improved haemopoesis;
  • improved immunological profile;
  • reduced levels of inflammatory markers;
  • higher quality of life.

Fetal stem cell therapy contributes to formation of anti-tumor immunity, which is crucial for preventing relapse and metastatic process. However, stem cell treatment is possible only after traditional treatment.

Our methods have been approved by the Ministry of Health of Ukraine on April 20, 1999 and have been recommended for use in clinical practice. 

Application of Fetal Stem Cell Suspensions in Complex Treatment of Cancer Patients (poster presentation).
Ukrainian, jpg, 2.6 Mb

Testimonials

Patient U.M., 57 C-r glandullae bilateralis; condition after combined therapy; prolongatio morbi 

Medical case reports

Left-side Wilms tumour, grade III, class II
Acute lymphoblastic leukemia
Breast cancer
Ovarian cancer grade IV, clinical group II
Tables
 

Request additional information
Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.

Our patents